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Purpose of review
This article reviews ‘no touch’ methods for disinfection of the contaminated surface environment of
hospitalized patients’ rooms. The focus is on studies that assessed the effectiveness of ultraviolet (UV)
light devices, hydrogen peroxide systems, and self-disinfecting surfaces to reduce healthcare-associated
infections (HAIs).
Recent findings
The contaminated surface environment in hospitals plays an important role in the transmission of several
key nosocomial pathogens including methicillin-resistant Staphylococcus aureus, vancomycin-resistant
Enterococcus spp., Clostridium difficile, Acinetobacter spp., and norovirus. Multiple clinical trials have
now demonstrated the effectiveness of UV light devices and hydrogen peroxide systems to reduce HAIs.
A limited number of studies have suggested that ‘self-disinfecting’ surfaces may also decrease HAIs.
Summary
Many studies have demonstrated that terminal cleaning and disinfection with germicides is often
inadequate and leaves environmental surfaces contaminated with important nosocomial pathogens. ‘No
touch’ methods of room decontamination (i.e., UV devices and hydrogen peroxide systems) have been
demonstrated to reduce key nosocomial pathogens on inoculated test surfaces and on environmental
surfaces in actual patient rooms. Further UV devices and hydrogen peroxide systems have been
demonstrated to reduce HAI. A validated ‘no touch’ device or system should be used for terminal room
disinfection following discharge of patients on contact precautions. The use of a ‘self-disinfecting’ surface
to reduce HAI has not been convincingly demonstrated.
Keywords
healthcare-associated infections, hydrogen peroxide systems, room decontamination, surface environment,
UV devices
INTRODUCTION
Healthcare-associated infections (HAIs) remain
an important source of patient morbidity and
mortality. Based on a large sample of U.S. acute care
hospitals, 4% of patients on any given day has
at least one HAI [1]. Based on this study, it was
estimated that 722000 HAIs occurred in 2011 in
U.S. acute care hospitals which resulted in 75000
deaths. The total annual costs for the five major
HAIs have been estimated to be $9.8 billion
(2012 US dollars) [2]. Dr Weinstein estimated that
the source of pathogens causing an HAI in the
intensive care unit was the patients’ endogenous
flora, 40–60%; cross-infection via the hands of
healthcare personnel (HCP), 20–40%; antibiotic-
driven changes in flora, 20–25%; and other (includ-
ing contamination of the environment), 20% [3].
Further, contamination of the hands of HCP could
result directly from patient contact or indirectly
from touching contaminated environmental surfa-
ces [4]. It has been shown that the gloves or hands of
HCP are just as likely to become contaminated from
touching a patient as touching an environmental
surface in a patient’s room [5,6].
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This article will briefly review the following:
first, data demonstrating that the contaminated
surface environment in a hospitalized patent’s room
plays an important role in the transmission of sev-
eral key healthcare-associated pathogens; second,
the rationale for the development and use of ‘no-
touch’ methods of room decontamination; and
third, the evidence supporting the effectiveness
from room decontamination of ultraviolet (UV)
light devices and hydrogen peroxide systems. This
review will focus on the recent studies demonstrat-
ing the effectiveness of ‘no-touch’ methods to
decrease HAIs, and update and expand a recent
paper that reviewed the ability of UV devices and
hydrogen peroxide systems to decrease HAI [7
&
].
ROLE OF THE CONTAMINATED SURFACE
ENVIRONMENT IN TRANSMISSIN OF
HEALTHCARE-ASSOCIATED PATHOGENS
Over the past decade, substantial scientific evidence
has accumulated that contamination of environ-
mental surfaces in hospital rooms plays an
important role in the transmission of several key
healthcare-associated pathogens, including methi-
cillin-resistant Staphylococcus aureus (MRSA), vanco-
mycin-resistant Enterococcus spp. (VRE), Clostridium
difficile,Acinetobacter spp., and norovirus [8–11,12
&
].
In general, all these pathogens share the following
characteristics: ability to survive for prolonged
periods of time on environmental surfaces, ability
to remain virulent after environmental exposure,
frequent contamination of the hospital environ-
ment, ability to colonize patients, ability to transi-
ently colonize the hands of HCP, and transmission
via the contaminated hands of HCP [8]. Norovirus
and C. difficile also are noted for a small inoculating
dose, and relative resistance to antiseptics and dis-
infectants used on environmental surfaces. Evi-
dence supporting the role of the contaminated
surface environment in the transmission of several
key healthcare-associated pathogens is summarized
as follows:
(1) The surface environment in rooms of colon-
ized or infected patients is frequently contami-
nated with the pathogen.
(2) The pathogen is capable of surviving on hos-
pital room surfaces andmedical equipment for
a prolonged period of time.
(3) Contact with hospital room surfaces or
medical equipment by HCP frequently leads
to contamination of hands and/or gloves.
(4) The frequency with which room surfaces are
contaminated correlates with the frequency of
hand and/or glove contamination of HCP.
(5) Daily use of a disinfectant instead of a deter-
gent reduces HAI rates.
(6) The patient admitted to a room previously
occupied by a patient colonized or infected
with a pathogen (e.g., MRSA, VRE, C. difficile,
Acinetobacter) has an increased likelihood of
developing colonization or infection with
that pathogen.
(7) Daily disinfection of room surfaces (versus
clean only if soiled) reduces acquisition of
pathogens on hands of HCP after contact with
surfaces or patients.
(8) Improved terminal cleaning of rooms leads to a
decreased rate of individual patient coloniza-
tion and/or infections.
(9) Improved terminal cleaning of rooms leads to a
decreased facility-wide rate of colonization
and/or infection.
(10) Improved terminal disinfection with a ‘no-
touch’ method leads to a decreased rate of
infection in patients subsequently admitted
to a room in which the prior occupant was
colonized or infected.
KEY POINTS
 The contaminated surface environment in patient rooms
has been linked to transmission of several important
nosocomial pathogens including MRSA, VRE, C.
difficile, Acinetobacter spp., and norovirus.
 Multiple studies have demonstrated that a substantial
number of room surfaces are not adequately cleaned
following patient discharge. Admittance to a room
previously occupied by a patient colonized or infected
with a multidrug-resistant pathogen (e.g., MRSA, VRE,
Acinetobacter) results in the newly admitted patient
having an increased risk of acquiring that pathogen by
39–353%.
 Because room surfaces are frequently not clean/
disinfected during terminal cleaning, multiple ‘no touch’
methodologies have been invented for terminal room
disinfection. The most studied technologies are UV
devices and hydrogen peroxide systems.
 UV devices and hydrogen peroxide systems have been
shown to eliminate clinically relevant numbers of
important nosocomial pathogens from inoculated test
objects and from actual room surfaces.
 Multiple clinical trials have now demonstrated that UV
devices and hydrogen peroxide systems decrease HAIs
due to multidrug-resistant pathogens. Although many of
the studies are of low quality, the consistency of the
studies and the few well designed studies lead one to
conclude that ‘no touch’ technologies are an effective
method for enhancing terminal room disinfection and
reducing the incidence of HAIs.
Nosocomial and healthcare related infections
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(11) Improved terminal disinfection with a ‘no-
touch’ method leads to a decreased rate of
facility-wide colonization and/or infection.
Importantly, admission to a room wherein the
previous occupant was colonized or infected with a
multidrug-resistant pathogen (e.g., MRSA, VRE, Aci-
netobacter spp.) has been shown to increase the risk
of acquiring that pathogen by 39–353% [9,13
&&
].
Recent studies have extended the findings on the
role of the environment in the transmission of noso-
comial pathogens. A variety of medically important
viruses have been found to be able to survive
for an epidemiologically important duration as
well as contaminate environmental surfaces
including influenza viruses, severe acute respiratory
disease-coronavirus and Middle East respiratory
syndrome-coronavirus [14
&
,15]. Carbapenem-resist-
ant Enterobacteriaceae (CRE) have been demonstrated
to contaminate the environmental surfaces near
colonized patients [16]. However, CRE strains do
not survive for prolonged periods on environmental
surfaces decreasing the risk that subsequent patients
would acquire the pathogen [17]. As noted above
the surface environment in rooms of colonized
or infected patients is frequently contaminated.
Recently, environmental contamination has been
demonstrated in the rooms of C. difficile excretors
without diarrhea or active infection [18–20]. Several
recent papers have demonstrated the presence of
medically important nosocomial pathogens (e.g.,
MRSA, VRE, C. difficile) on the surfaces in rooms of
patients not colonized or infected with the pathogen
thus emphasizing the need for appropriate terminal
disinfection of all hospital rooms [21,22].
RATIONALE FOR USING A ‘NO-TOUCH’
METHOD FOR TERMINAL ROOM
DISINFECTION
Multiple studies have demonstrated that surfaces
in hospital rooms are poorly cleaned during
terminal cleaning. Although methods of assessing
the adequacy of cleaning varied (i.e., visibly clean,
ATP bioluminescence, fluorescent dye, aerobic plate
counts), several studies have demonstrated that less
than 50% of room surfaces were properly cleaned
[23,24]. Improved cleaning has been demonstrated
to lead to reductions in HAIs [25]. However, it has
been reported that there is a paucity of high-quality
studies demonstrating that improved cleaning/
disinfection reduces HAIs [26]. Importantly, the
studies that have assessed interventions to improve
cleaning have reported that following the interven-
tion, 5 to 30% of surfaces remain potentially
contaminated [24].
‘NO TOUCH’ METHODS FOR
DECONTAMINATING HOSPITAL ROOM
SURFACES
As noted above, multiple studies have demonstrated
that environmental surfaces and objects in rooms
are frequently improperly cleaned/disinfected and
these surfaces may be important in transmission of
healthcare-associated pathogens. Further, although
interventions aimed at improving cleaning thor-
oughness have demonstrated effectiveness, many
surfaces remain inadequately cleaned and therefore,
potentially contaminated. For this reason, multiple
new methodologies have been developed to decon-
taminate environmental surfaces (i.e., ‘no touch’
methods) (Table 1) [7
&
,27,28,29
&&
,30
&&
,31
&
]. In
addition, new technologies have been developed
to inhibit the growth of microbes on environmental
surfaces (i.e., ‘self-disinfecting surfaces’) (Table 1)
[32,33,34
&&
].
There are now substantial data demonstrating
the effectiveness of ‘no touch’ methodologies for
terminal room disinfection. These methodologies
fall into two broad classes; devices that use UV light
and systems that generate hydrogen peroxide
Table 1. ‘No touch’ methodologies for decontamination of
hospital room surfaces
Room decontamination methodologies for terminal room
decontamination
Ultraviolet light devices
UV-C
UV-pulsed xenon
Hydrogen peroxide systems
Hydrogen peroxide vapor (30–35% H2O2)
Aerosolized hydrogen peroxide systems (5–6% H2O2 plus
silver)
Room decontamination methodologies for continuous
decontamination
High-intensive narrow-spectrum light
Low dose continuous hydrogen peroxide
Spot surface decontamination methodologies
Handheld UV devices
Steam cleaning
‘Self-disinfecting’ surfaces
Antimicrobial coatings
Copper
Silver
Triclosan
Polycationic and light-activated antimicrobial surfaces
Bacteriophage-modified surfaces
Altered topography [e.g., shark skin-like surfaces such as
Sharklet AF (Sharklet Technologies, Alachua, Florida)]
No touch methods Weber et al.
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[7
&
,27,28,29
&&
,30
&&
,31
&
]. Ultraviolet light – C (UV-C)
devices use specifically designated wavelengths
(254nm range) and deliver targeted doses for vege-
tative bacteria (e.g., 12000mWs/cm2) or for spores
(22000–36,000mWs/cm2) on surfaces, while the
UV pulsed xenon devices emit broad spectrum UV
in short pulses [28]. There are currently two major
hydrogen peroxide systems [27]. First, H2O2 vapor
systems that deliver a heat-generated vapor of 30–
35% (w/w) aqueous H2O2 through a high-velocity
air stream to achieve homogeneous distribution
throughout an enclosed area. Second, aerosolized
H2O2 systems deliver a pressure-generated aerosol
[27]. The systems employed most frequently in
healthcare use a solution containing 5–6% H2O2
and less than 50ppm silver. Aerosolized droplets
are introduced into an enclosure via a
unidirectional nozzle.
Ultraviolet light devices
Multiple studies have assessed the effectiveness of
UV devices to inactivate microbes inoculated onto
various test surfaces which are then placed in a
typical hospital room [7
&
,29
&&
,30
&&
]. In general, the
inoculating doses weremore than 4-log10 in order to
fully assess the level of inactivation. The most com-
monly tested organisms were epidemiologically
important healthcare-associated pathogens and
included MRSA, VRE, C. difficile, and Acinetobacter
spp. From these studies one can conclude that more
than 3-log10 vegetative organisms can be killed in
5–25min by UV, but it requires greater time and
energy to kill a spore-forming organism such as C.
difficile. All studies have reported reduced killing via
indirect versus direct line of sight from the UV
device. The time needed to inactivate pathogens
has been demonstrated to be shortened by use of
UV reflective wall paint for multiple different UV-C
devices [35,36]. In addition, multiple studies have
assessed the effectiveness of UV devices to decon-
taminate actual hospital rooms following discharge
of a patient colonized or infected with a multidrug-
resistant pathogen [7
&
,29
&&
,30
&&
]. Pathogens eval-
uated included MRSA, VRE, Acinetobacter, and C.
difficile. Cycle times for vegetative bacteria ranged
from 10 to 25min and for C. difficile from 10 to
45min. In all cases the frequency of positive surface
sites post-treatment was less than 11% and in many
cases was less than 1%. The reported log10
reductions were always greater than 2. It is import-
ant to understand that the bioburden on contami-
nated surfaces in hospital rooms is relatively low and
therefore the reduction in frequency of positive
surface sites is a better measure of UV effectiveness
than the log10 reduction.
Hydrogen peroxide systems
The effectiveness of H2O2 vapor systems has been
well studied [7
&
,27,37]. Multiple studies have dem-
onstrated the ability of H2O2 vapor systems to inac-
tivate viruses and bacteria inoculated onto test
surfaces. H2O2 vapor systems are capable of inacti-
vating nonenveloped viruses, mycobacteria, and
even high numbers of bacterial spores. Further,
multiple studies have demonstrated the ability
of hydrogen peroxide systems to reduce multi-
drug-resistant organisms (MDROs) contaminating
surfaces in hospital rooms [7
&
,27,29
&&
,30
&&
]. In the
majority of studies, the number of contaminated
surfaces was reduced to 0% and in all cases to less
than 5%. Of note, none of the studies described
the log10 reduction in pathogens. It is important
to realize that there are key differences in the man-
ner in which the various H2O2-based room disinfec-
tion systems generate and deliver their active agent.
H2O2 vapor systems use heat to generate hydrogen
peroxide vapor (HPV) from 30 to 35% H2O2, while
aerosolized H2O2 systems use pressure or ultrasonic
nebulization to generate H2O2 from 5 to 6%. These
systems have fundamental differences which result
in the H2O2 vapor systems having an increased level
of efficacy, homogeneous distribution, and shorter
cycle times [27,37,38].
Recent studies assessing the use parameters
and effectiveness of ultraviolet devices and
hydrogen peroxide systems
Hydrogen peroxide vapor has been demonstrated to
inactivate key pathogens (i.e., MRSA, VRE, Acineto-
bacter) on both porous and nonporous surfaces [39].
Several recent studies have assessed the effect
of use parameters on the effectiveness of UV devices.
Boyce et al. [40] studied the impact of distance and
orientation using inoculated (MRSA, VRE, C. diffi-
cile) test objects on the effectiveness of a single UV-C
device. They concluded that UV-C irradiance,
dosage, and antimicrobial effect received from a
mobile UV-C device varied substantially based on
location in a room relative to the UV-C device.
Cadnum et al. [41] compared UV-C devices and
concluded that variations in test methods can sig-
nificantly impactmeasured reductions in pathogens
by UV-C devices during experimental testing.
Specifically, they reported that the following factors
affected pathogen killing: spreading the inoculum
over a larger surface area enhanced killing, orien-
tation of the carriers in parallel rather than perpen-
dicular enhanced killing, and different types of
organic load affecting killing. However, type of
carrier, variation in carrier height, and interrupted
cycles had no effect on killing.
Nosocomial and healthcare related infections
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Few studies have directly compared the effec-
tiveness of different ‘no touch’ methods. Nerandzic
et al. [42] compared a UV-C device with a UV light –
pulsed xenon (UV-PX) device at manufacturer
recommended exposure times and demonstrated
that the UV-C device had superior killing of MRSA,
VRE, and C. difficile. Increasing distance from the
UV-PX device dramatically reduce killing efficacy
whereas pathogen concentration, organic load, and
shading did not. Wong et al. [43] compared two
different UV-C devices. Both were effective in killing
MRSA and VRE up to concentrations of 106CFU/ml
when suspended in a isotonic saline. However, one
device was approximately seven times more effec-
tive in killing MRSA and VRE when they were sus-
pended in a protein solution.
CLINICAL TRIALS USING ‘NO TOUCH’
ROOM DECONTAMINATION METHODS
Multiple clinical trials have assessed the efficacy of a
UV device or hydrogen peroxide system for terminal
room decontamination to reduce HAIs from multi-
drug-resistant pathogens (Table 2). Thirteen studies
have now demonstrated that the use of a ‘no touch’
device or system reduces the incidence or prevalence
of selected MDROs. However, overall the quality of
these studies, in general, is poor for the following
three reasons: first, most of the studies used a
before–after design which is more likely subject to
bias than cross-over studies or randomized clinical
trials (however, the use of controls as was done in
some studies can reduce the possibility of bias);
second, almost all of the studies did not provide a
prespecified statistically valid measure of success
with a prestudy sample size calculation; and third,
most of the studies did not assess potential con-
founding that could explain the decrease in multi-
drug-resistant pathogens such as hand hygiene
compliance and compliance with appropriate sur-
face cleaning prior to decontamination. Another
limitation to assessing the relative effectiveness of
different ‘no touch’ methods is that no study com-
pared two different methods. However, the multi-
tude of positive studies suggests that ‘no touch’
technologies do indeed decrease HAIs. Further,
some studies described below were well designed
and assessed potential confounders. Along with
the studies listed in Table 2, one before–after study
used a UV-PX device nightly in the operating rooms
and reported a decrease in surgical site infections for
class 1 procedures [57]. The mechanism for this
reduction is unclear because the surface environ-
ment is not felt to have a substantial impact on the
likelihood of surgical site infections.
Several studies warrant detailed discussion,
including the studies by Passaretti et al. [53], by
Pegues et al. [47], and by Anderson et al. [46]. Passar-
etti et al. [53] performed a 30-month prospective
cohort (before–after study that was strengthened by
the use of concurrent controls) intervention using a
HPV device on six high-risk units in a 994-bed
Table 2. Clinical trials of ‘no touch’ methods: UV devices and hydrogen peroxide systems
Year, author Device/system Study design Setting Selected resultsa
2016, Vianna et al. [44] UV-PX Before–after Community hospital Facility wide: #C. difficile, #all MDROs
(MRSA, VRE, CDI)
2015, Horn and Otter [45] HP vapor Before–after Hospital #CDI, #VRE, #ESBL GNB
2015, Anderson et al. [46] UV-C RCT 9 hospitals #All MDROs (MRSA, VRE, CDI)
2015, Pegues et al. [47] UV-C Before–after Academic center #CDI
2015, Nagaraja et al. [48] UV-PX Before–after Academic center #CDI
2015, Miller et al. [49] UV-PX Before–after Nursing home #CDI
2014, Mitchell et al. [50] Dry HP vapor Before–after Hospital #MRSA colonization and infection
2014, Haas et al. [51] UV-PX Before–after Academic center #CDI, #MRSA, #VRE, #MDRO GNB,
all MDROs
2013, Manian et al. [52] HP vapor Before–after Community hospital #CDI
2013, Passaretti et al. [53] HP vapor Prospective cohort Academic center #VRE, #all MDROs (MRSA, VRE, CDI)
2013, Levin et al. [54] UV-PX Before–after Community hospital #CDI, #MRSA,
2011, Cooper et al. [55] HP vapor Before–after (2 cycles) Hospitals #CDI (cases; incidence not significant)
2008, Boyce et al. [56] HP vapor Before–after Community hospital #CDI
CDI, Clostridium difficile infection; ESBL, extended spectrum beta-lactamase producers; GNB, Gram negative bacteria; HP, hydrogen peroxide; MDRO, multidrug-
resistant organism; MRSA, methicillin-resistant Staphylococcus aureus; UV-C, ultraviolet light – C; UV-PX, ultraviolet light – pulsed xenon; VRE, vancomycin-
resistant Enterococcus.
aAll listed results were statistically significant (see reference for more details).
No touch methods Weber et al.
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tertiary care hospital. Patients admitted to rooms
decontaminated using HPV were 64% less likely
to acquire any multidrug-resistant pathogen [inci-
dence rate ratio (IRR), 0.36; P<0.001] and 80% less
likely to acquire VRE (IRR, 0.20; P<0.001). The
risk of acquiring C. difficile, MRSA, and multidrug-
resistant Gram-negative bacilli was reduced, but
not significantly. The proportion of rooms environ-
mentally contaminated with MDROs was reduced
significantly on the HPV units (relative risk, 0.65;
P¼0.03).
Pegues et al. [47] performed a prospective
cohort (before–after study) in three haematol-
ogy–oncology units to assess the efficacy of
a UV-C device to reduce C. difficile infections
(CDIs). Importantly, rooms were disinfected with
bleach prior to use of the UV-C device. A significant
association between UV-C use and a decline in
CDI incidence was noted on study units (IRR,
0.49; 95% CI, 0.26–0.94; P¼0.03) but not on the
nonstudy units (IRR, 0.63; 95% CI, 0.38–1.06;
P¼0.08). Importantly, hand hygiene compliance,
which was monitored by observation, and room
cleaning compliance, which was monitored using
ATP bioluminescence, were similar in the baseline
and intervention periods (D. Pegues, personal
communication).
The study by Anderson et al. [46] is the first
randomized clinical trial to assess a ‘no touch’
method (UV-C, Tru-D) for terminal room disinfec-
tion. Specifically this was a prospective,multicenter,
cluster-randomized, crossover trial in nine hospitals
which evaluated three strategies for enhanced ter-
minal room disinfection: standard quaternary
ammonium compound plus UV-C, bleach alone,
and bleach plus UV-C. Patients colonized or infected
with MRSA or VRE, or with CDI were considered
‘seed rooms’ with ‘exposed’ patients being patients
subsequently admitted to a ‘seed room.’ Exposed
patients were followed for the development of an
HAI due to a target pathogen. Compliance with
hand hygiene and terminal room cleaning were
measured and there were no differences in these
potential confounders among the baseline group
(quaternary ammonium compound alone) and
the three intervention arms. The study showed that
enhanced room decontamination strategies (i.e.,
bleach and/or UV-C decontamination) decreased
the clinical incidence of acquisition of target
MDROs (i.e., MRSA, VRE, C. difficile) by �10 to
30% (P¼0.036).
‘No-touch’ room disinfection devices have been
used as a component to control healthcare-associ-
ated outbreaks [7
&
]. The outbreaks involved S. aur-
eus, multidrug-resistant Gram-negative bacilli, C.
difficile, and Acinetobacter baumannii plus MRSA.
The device used in the great majority of cases was
a HPV system.
CHOOSING A ‘NO TOUCH’ DEVICE OR
SYSTEM
Hospitals should use a ‘no touch’ device or system
for terminal room decontamination after dis-
charge of patients on contact precautions. How-
ever, the multitude of commercially available
devices and systems makes choosing a specific
device or system difficult. UV devices may vary
because of differences in UV wavelength, bulb size,
energy output, ability to measure energy delivery,
and cost. Similarly, hydrogen peroxide systems
differ with regard to concentration, use of other
microbicides, and method of injecting hydrogen
peroxide into a room or space, and cost. For these
reasons, infection control professionals should
review the peer-reviewed literature and choose
for purchase only devices with demonstrated
bactericidal capability as assessed by the carrier
test method and/or ability to disinfect actual
patient rooms. Ultimately, one should choose
only devices that have demonstrated the ability
to reduce HAIs [7
&
].
Further, infection control professionals should
be aware of the advantages and disadvantages of
both UV and hydrogen peroxide systems (Table 3).
Because UV devices and hydrogen peroxide systems
will not physically clean a room (e.g., remove dust or
stains), room cleaning must precede disinfection.
‘No touch’ systems should be seen as adjunctive
methods of room decontamination. A recent
modeling study revealed the importance of hand
hygiene to reduce HAIs and reported that a 2 : 1
improvement in terminal cleaning compared
with hand hygiene was required to match an equal
reduction in acquisition rates [58]. Another
study implemented a three sequential tiered set of
interventions: first, fluorescent markers to provide
monitoring and feedback on thoroughness of clean-
ing; second, addition of a UV-C device for adjunc-
tive decontamination of rooms that housed a
patient with CDI; and third, enhanced standard
disinfection ofC. difficile rooms. During the baseline
period 67% of the C. difficile rooms had positive
cultures after disinfection, whereas with interven-
tions 1, 2, and 3, the percentages of rooms
with positive cultures after disinfection was reduced
to 57, 35, and 7%, respectively [59].
CONCLUSIONS
‘No touch’ technologies have been demonstrated to
kill nosocomial pathogens on inoculated test
Nosocomial and healthcare related infections
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surfaces, and on actual environmental surfaces and
equipment in hospital rooms. Further, more than a
dozen clinical trials have now demonstrated that
use of one of these technologies can reduce HAIs.
Additional well-designed studies (e.g., randomized
clinical trials) should be undertaken to assess the
degree to which these technologies can reduceHAIs.
Studies directly comparing different technologies
would be extremely useful. Finally, cost–benefit
analyses should be conducted.
Because there are substantial differences
between UV devices and hydrogen peroxide systems
and within each technology there are multiple com-
mercial choices, healthcare providers should rely on
the peer-reviewed literature to validate specific devi-
ces and systems prior to purchase.
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